ロード中...
Safety and Efficacy of Brentuximab Vedotin in the Treatment of Classic Hodgkin Lymphoma
Classical Hodgkin lymphoma (cHL) is a B-cell-derived lymphoid malignancy with the most favorable prognosis among various adult malignancies. However, once it becomes refractory disease to chemotherapy or relapses after high-dose chemotherapy (HDC) with autologous stem cell transplantation (ASCT), it...
保存先:
| 出版年: | Onco Targets Ther |
|---|---|
| 主要な著者: | , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
Dove
2020
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7320890/ https://ncbi.nlm.nih.gov/pubmed/32606807 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/OTT.S193951 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|